Children's Medical Center Dallas is a nationally ranked pediatric acute care teaching hospital located in Dallas, Texas, USA. The hospital has 496 pediatric beds and is affiliated with the University of Texas Southwestern Medical School.

There are 496 beds in Children's Medical Center Dallas.

During the past decade, Children's Medical Center Dallas conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 80 clinical trials were completed, i.e. on average, 65.6% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 51 clinical trials were completed. i.e. 104.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Medical Center Dallas" #1 sponsor was "University of Texas Southwestern Medical Center" with 45 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 23 trials sponsored, "Aimmune Therapeutics, Inc." with 7 trials sponsored, "Children's Hospital of Philadelphia" with 7 trials sponsored and "DBV Technologies" with 7 trials sponsored. Other sponsors include 138 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Medical Center Dallas" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 21 trials as a collaborator, "Children's Medical Center Dallas" with 11 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 10 trials as a collaborator, "Seattle Children's Hospital" with 7 trials as a collaborator and "National Marrow Donor Program" with 6 trials as a collaborator. Other collaborators include 235 different institutions and companies that were collaborators in the rest 165 trials.

According to Clinical.Site data, the most researched conditions in "Children's Medical Center Dallas" are "HIV Infections" (24 trials), "Peanut Allergy" (13 trials), "Neuroblastoma" (7 trials), "Muscular Dystrophy, Duchenne" (5 trials) and "Anemia, Sickle Cell" (4 trials). Many other conditions were trialed in "Children's Medical Center Dallas" in a lesser frequency.

Most popular intervention types in "Children's Medical Center Dallas" are "Drug" (126 trials), "Device" (28 trials), "Biological" (25 trials), "Other" (16 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Zidovudine" (10 trials), "Didanosine" (7 trials), "Cyclophosphamide" (5 trials) and "Nevirapine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Children's Medical Center Dallas" are 221 trials for "All" genders, 10 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 67 active trials in "Children's Medical Center Dallas". 1 are not yet recruiting, 43 are recruiting, 20 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 126 completed trials in Children's Medical Center Dallas, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Medical Center Dallas, 18 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 40 trials that are defined as “Not Applicable".

Children's Medical Center Dallas has several departments that took part in Clinical trials: "Children's Medical Center, Dallas Center for Cancer and Blood Disorders" - 2 trials, "Children's Health Specialty Center Dallas Campus" - 2 trials